INM – inmed pharmaceuticals inc. - common shares (US:NASDAQ)
Stock Stats
News
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program [Yahoo! Finance]
InMed Pharmaceuticals (NASDAQ:INM) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K InMed Pharmaceuticals For: Mar 23
Form S-3 InMed Pharmaceuticals
Form 8-K InMed Pharmaceuticals For: Mar 09
Form 8-K InMed Pharmaceuticals For: Mar 04
Form 8-K InMed Pharmaceuticals For: Feb 11
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.